A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Issue 14 (6th December 2022) - Nath, Karthik; Shekarkhand, Tala; Salcedo, Meghan; Derkach, Andriy; Rueda, Siobhan; Chansakul, Aisara; Hulcrantz, Malin; Korde, Neha; Shah, Urvi A.; Tan, Carlyn; Chung, David J.; Lahoud, Oscar B.; et al.